Enhancement of recombinant human bone morphogenetic protein-2 (rhBMP-2)-induced new bone formation by concurrent treatment with parathyroid hormone and a phosphodiesterase inhibitor, pentoxifylline

Author: Horiuchi Hiroshi   Saito Naoto   Kinoshita Tetsuya   Wakabayashi Shinji   Tsutsumimoto Takahiro   Otsuru Satoru   Takaoka Kunio  

Publisher: Springer Publishing Company

ISSN: 0914-8779

Source: Journal of Bone and Mineral Metabolism, Vol.22, Iss.4, 2004-07, pp. : 329-334

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content